Zinc, taurine, and epilepsy.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000328:Adult; D000613:Aminobutyrates / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D003300:Copper / Q000378:metabolism / Q000494:pharmacology; D004195:Disease Models, Animal; D004827:Epilepsy / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D008345:Manganese / Q000378:metabolism / Q000494:pharmacology; D008526:Medulla Oblongata / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D009186:Myelin Sheath / Q000378:metabolism; D010042:Ouabain; D011188:Potassium / Q000134:cerebrospinal fluid / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000378:metabolism; D013574:Synaptosomes / Q000378:metabolism; D013654:Taurine / Q000378:metabolism* / Q000627:therapeutic use*; D014316:Tritium; D015032:Zinc / Q000378:metabolism* / Q000494:pharmacology
D000613:Aminobutyrates; D014316:Tritium; D013654:Taurine; D008345:Manganese; D010042:Ouabain; D003300:Copper; D012964:Sodium; D000251:Adenosine Triphosphatases; D015032:Zinc; D011188:Potassium